股票收购
Search documents
90后游资大佬征婚“牵”出这只大牛股
Sou Hu Cai Jing· 2025-12-08 12:48
《星岛》记者 吴鸣 上海报道 近日,90后游资大佬刘鑫通过个人公众号发文征婚引爆全网,最终能否成功觅得佳偶尚且不知,但这波 流量是赚到了。不仅这篇征婚启事的阅读点击已超过10万+,且至今每篇发文,流量都可上万。 据说,征婚的效果也立竿见影,刘鑫的微信每天收到数百个好友申请,让他应接不暇。不过,对金融圈 而言,关注的焦点很快从征婚本身转移到了他背后的财富实力上,特别是他提到的"超10家上市公司十 大股东"身份。 亮相6只A股前十股东 据A股上市公司三季报,"刘鑫"出现在大金重工(002487.SZ)、中电电机(603988.SH)大元泵业 (603757.SH)、济民健康(603222.SH)、江顺科技(001400.SZ)、龙星科技(002442.SZ)6家上市 公司的前十大流通股东名单中,分别持有1226.51万股、628.95万股、477.77万股、888.88万股、35.49万 股和666.39万股,而在大金重工和江顺科技两家公司中,位列第一大自然人股东。 若上述"刘鑫"均为同一人,那么,以12月8日收盘价计算,这6只股票的合计持仓市值约为11.92亿元。 刘鑫在征婚启事中仅提到两家上市公司,它们应该具 ...
15连板牛股复牌跌停 收购方已启动独立IPO相关工作
Zheng Quan Shi Bao Wang· 2025-10-16 02:12
Core Viewpoint - Tianpu Co., Ltd. (605255) experienced a significant drop in stock price after a 15-day consecutive limit-up period, raising concerns about trading risks and potential price corrections [1][2] Group 1: Stock Performance - Tianpu Co., Ltd. opened at a limit-down price of 100.15 yuan per share, with over 25,000 shares on the limit-down order [1] - The stock had previously increased by 317.72% over the 15 trading days from August 22, 2025, to September 23, 2025 [1] Group 2: Acquisition and Business Operations - The acquiring party, Zhonghao Xinying, has confirmed that it has initiated the process for an independent IPO and is currently in the shareholding reform stage [1] - There are no plans for significant changes to the main business operations of Tianpu Co., Ltd. in the next 12 months, nor any plans for asset sales, mergers, or major restructuring [1][2] - The main products of the company include polymer fluid pipeline systems and sealing system components, primarily used in traditional fuel vehicle manufacturing [2]
Akero Therapeutics Stock Surges on Novo Nordisk Buyout
Schaeffers Investment Research· 2025-10-09 14:11
Core Insights - Novo Nordisk has agreed to acquire Akero Therapeutics for up to $5.2 billion in cash, leading to a 1% decline in Novo Nordisk's stock price to $59, while Akero's stock rose by 16.8% to $54.29 following the announcement [1] - Year-to-date, Novo Nordisk's stock has decreased by 31%, struggling to recover from a significant drop of nearly 22% after its earnings report in late July, while Akero has outperformed with a 95% increase year-to-date [2] - The options market shows a bullish sentiment for Novo Nordisk, with a high put/call volume ratio indicating potential headwinds if this sentiment unwinds [3] - Both companies exhibit low volatility expectations in the options market, with Schaeffer's Volatility Index indicating relatively low pricing for options [4] Company Performance - Novo Nordisk's stock is currently facing pressure, trading at $59, down 31% year-to-date, and has not recovered from a significant post-earnings drop [2] - Akero Therapeutics has seen a strong performance, with a 95% increase year-to-date and a notable rise in stock price following the acquisition announcement [2] Market Sentiment - The options market for Novo Nordisk has been notably bullish, with a put/call volume ratio of 3.96, placing it in the 90th percentile of annual readings, suggesting potential for increased volatility if sentiment shifts [3] - The Schaeffer's Volatility Index for both Novo Nordisk and Akero indicates low volatility expectations, with values of 54% and 61%, respectively, suggesting a calm market outlook for options trading [4]
财联社8月5日早间新闻精选
Xin Lang Cai Jing· 2025-08-05 00:22
Group 1 - Taxpayers in China are required to declare and pay taxes on overseas income from stock trading, as there are no tax exemptions for such income according to the personal income tax law [1] - Shanghai has issued measures to support enterprises in enhancing basic research, aiming to attract more companies in integrated circuits, biomedicine, and artificial intelligence to join the "Explorer Program" [2] - Significant progress has been made in HIV vaccine research in China, with the completion of the first phase clinical trial of a replicating Tian Tan smallpox vaccine vector HIV vaccine [3] Group 2 - In July 2025, A-share new accounts reached 1.96 million, showing a year-on-year increase of 71% compared to July 2024, and a month-on-month increase of 19.27% [4] - The wholesale sales of new energy passenger vehicles in China reached 1.18 million units in July, marking a year-on-year growth of 25% but a month-on-month decline of 4% [6] - Companies such as Fengli Intelligent and Lvtong Technology are planning to raise funds through private placements and acquisitions, indicating active capital market activities [7][8] Group 3 - Guizhou Moutai has repurchased a total of 3.45 million shares, with a total payment of 5.301 billion yuan [10] - The net profit of Shangwei New Materials for the first half of the year is expected to be 29.9 million yuan, a year-on-year decrease of 32.91% [10] - The net profit of Haowei Group is projected to increase by 39% to 50% year-on-year for the first half of the year [10] Group 4 - China Shipbuilding Industry Corporation plans to absorb China Shipbuilding, which may lead to the termination of the latter's stock listing [12] - The U.S. President has indicated plans to increase tariffs on India due to its oil trade practices, which could impact international trade dynamics [13] - The Federal Reserve's comments suggest potential interest rate cuts, which could influence market conditions and investment strategies [14]